>> >> Top Precision Medicine Solution Companies in Europe

>> >> Top Precision Medicine Solution Companies in Europe

Theracell: Making Advanced Therapies Accessible and Affordable

Top 10 Precision Medicine Solution Companies in Europe - 2021

The technologies that underpin healthcare have been evolving rapidly in the recent years, helping to drive digital transformation in the entire life sciences realm. Especially in precision medicine or personalised medicine—environments where harnessing new technologies can help in delivering complex, patient-specific pharmaceutical or medical devices—embracing digitalisation is the key to enable both standardisation and personalisation of patient care.

In this regard, technologies like AI, big data analytics, bioinformatics and the internet of things (IoT), among others, are already proving their potentials. They have the ability to extend their influence over the sector by enabling precision medicine. Since this care procedure is based on data collection, analysis, and problem-solving driven by the analysis, such technologies are imperative and a perfect fit for it.

At this juncture, a variety of precision medicine solution providers in the Europe are entering the market to cater to the different needs of enterprises. To help healthcare professionals choose the solution that best fits their requirements, Healthcare Tech Outlook has compiled lists of the most promising precision medicine solution providers. Besides, the magazine also comprises insights from thought leaders in the sector on the industry trends, best practices, recent innovations, and their advice for aspiring CXOs.

We present to you Healthcare Tech Outlook’s “Top 10 Precision Medicine Solution Providers in Europe – 2021,”

Top Precision Medicine Solution Companies in Europe

Top Precision Medicine Solution Companies in Europe

AstraZeneca

Astra Zeneca focuses on providing medicines that make a real difference to patient care, and precision medicine is at the heart of its commitment to patient-centric science and innovation. Using innovative diagnostic tests to evaluate individual responses to treatments, AZ aims to select appropriate and optimal therapies for patients who will benefit from them most. Further, AZ applies precision medicine approaches across all therapy areas and in over eighty per cent of drug projects in its pipeline, which sets them apart from its competitors. AZ's precision medicine centres on delivering the most appropriate therapy to a patient based on their disease's clinical and molecular features

Foundation Medicine

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer

Theracell

Theracell is one of the most notable and innovative biotechnology companies that focuses on precision medicine, cell and gene therapies.

Visiopharm

Visiopharm is a worl+B7:E11d leader in AI-based image analysis and workflow standardization solutions for digital pathology. Visiopharm’s pioneering image analysis tools support thousands of scientists, pathologists, and image analysis experts in both academic institutions and the biopharmaceutical industry. AI-based image analysis and tissue mining tools support research and drug development research worldwide, while their CE-IVD APPs support primary diagnostics. With the most advanced and sophisticated artificial intelligence and deep learning, they deliver tissue data mining tools, precision results, and workflows. Visiopharm was founded in 2001 and is privately owned. The company operates internationally with over 900 licenses in more than 38 countries. Company headquarters are in Denmark’s Medicon Valley, with further offices in London, England, Munich, Germany, and Westminster, Colorado

bioMérieux

A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products

Intomics

Intomics is a highly specialized biomedical data analytics company. We derive core biological insights from analysis and integration of biomedical big data. We increase the success rate of drug discovery and development projects for clients in the pharmaceutical industry. With our world-leading expertise, unique value-added data sets and sophisticated systems biology platform, we help our clients. To each client and project we deliver scientifically solid and innovative data analysis solutions tailored and executed by our panel of world-leading experts.

Medtronic

A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives. We fuse technology, a deep understanding of the body, and leading medical science to create never-before-seen solutions. Whether it’s less invasive surgical approaches to minimize a patient's downtime or creating the smallest pacemaker, our potential to transform lives knows no limits. We take insights gleaned from data to make substantial improvements in care, tailoring therapies in real time. And our work on the forefront of technology pushes care forward, such as reimagining robotic-assisted surgery to bring advanced precision and predictability to more people. Empathy inspires our technologies that smartly adapt to a patient’s lifestyle and don’t get in the way of the things they love to do. We’re working to create adaptive technologies to alleviate patients’ concerns and put control in their hands

Novartis

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world

OncoDNA

OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late stage cancer patients, but also supports research and drug development in cancer and genetic diseases. Since its early days in 2012, OncoDNA grew into a corporate group of companies with world-renown expertise. The Group offers a unique portfolio that combines NGS services, biomarker testing, data interpretation software, and clinical decision support tools. OncoDNA is headquartered in Belgium, and its entities – Biosequence and IntegraGen – are based in Spain, France and the United States. The Group employs over 100 employees across 9 countries, works with an international network of 35 distributors and collaborates with both European-based and US-based subcontracted accredited laboratories

QIAGEN

QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics).